More Screening Needed Before Non-Cardiac Surgery

According to this recent document by the American Heart Association (AHA), troponin should be monitored for at least 3 days after surgery.

Más screening es necesario previo a una cirugía cardíaca

With about 20% of patients (most of them, asymptomatic) showing elevated troponin after a non-cardiac surgery, this new AHA document recommends monitoring, for at least two days, patients with moderate to severe ischemia.

Myocardial injury after non-cardiac surgery was first associated with increased mortality in 2014. At the time, researchers interpreted that these events could be triggered by an increased burden of risk factors, including patients over 75 years of age with sleep apnea, anemia, cardiac failure, diabetes, and hypertension.

The moral of this work would be that myocardial injury after non-cardiac surgery is frequent, silent, and fatal—so it should be taken into account.

Current evidence shows that patients who develop injury have four times higher 30-day mortality, and about 90% of this population has no identifiable symptoms.

Given that most subjects develop symptoms within 24 hours, the document suggests dosing troponins for 48 to 72 hours in patients at moderately high risk.


Read also: Hypertensive Patients: Maximizing Doses or Adding New Drugs.


The idea of performing ischemia-evoking tests prior to non-cardiac surgery left us without much to do if a patient with normal results developed an injury. Now we can comprehend the elevation and re-stratify patients, reducing their future risk.

Post-surgical injury should end in a direct referral to a cardiologist to evaluate the indication for aspirin and lifestyle changes. Patient could interpret this as secondary prevention.

CIR-0000000000001024

Original Title: Diagnosis and management of patients with myocardial injury after noncardiac surgery: a scientific statement from the American Heart Association.

Reference: Kurt Ruetzler et al. Circulation. 2021 Oct 4;CIR0000000000001024. Online ahead of print. doi: 10.1161/CIR.0000000000001024. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...